Trial intelligence / Profile preview

Generic risedronate in Thai postmenopausal osteoporosis

TCTR20240427002Unknown

Sponsor
Ratchadaphiseksomphot Endowment Fund
Start
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Trial of risedronate in osteoporosis, sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoints: Change in bone turnover markers and Change in bone mineral density. Status: unknown.

02

Drugs

risedronate
03

Conditions

osteoporosis

Beyond the preview

Go deeper on TCTR20240427002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240427002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call